Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Scheen, A.
1374  Ergebnisse:
Personensuche X
?
1

The discovery of insulin:

Diem, P. ; Ducluzeau, P.H. ; Scheen, A.
Diabetes Epidemiology and Management.  5 (2022)  - p. 100049 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Pourquoi la metformine en première intention dans le diabèt..:

Scheen, A.
Annales d'Endocrinologie.  83 (2022)  5 - p. 275-276 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Exciting breakthroughs in the management of diabetes mellit..:

Scheen, A.J.
Diabetes Epidemiology and Management.  1 (2021)  - p. 100005 , 2021
Link: https://doi.org/10.1016/..
 
?
4

Reduction in HbA1c with SGLT2 inhibitors vs. DPP-4 inhibito..:

Scheen, A.J.
Diabetes & Metabolism.  46 (2020)  3 - p. 186-196 , 2020
Link: https://doi.org/10.1016/..
 
?
5

Metformin and COVID-19: From cellular mechanisms to reduced..:

Scheen, A.J.
Diabetes & Metabolism.  46 (2020)  6 - p. 423-426 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Prognostic factors in patients with diabetes hospitalized f..:

Scheen, A.J. ; Marre, M. ; Thivolet, C.
Diabetes & Metabolism.  46 (2020)  4 - p. 265-271 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Challenging 2019 ESC guidelines for the management of type ..:

Scheen, A.J.
Diabetes & Metabolism.  46 (2020)  3 - p. 181-185 , 2020
Link: https://doi.org/10.1016/..
 
?
8

SGLT2 inhibition during the COVID-19 epidemic: Friend or fo..:

Scheen, A.J.
Diabetes & Metabolism.  46 (2020)  5 - p. 343-344 , 2020
Link: https://doi.org/10.1016/..
 
?
9

Assessment of the benefit–risk balance of SGLT2 inhibitors:..:

Scheen, A.J. ; Darmon, P. ; Hanaire, H.
Diabetes & Metabolism.  45 (2019)  4 - p. 319-321 , 2019
Link: https://doi.org/10.1016/..
 
?
10

Beneficial effects of SGLT2 inhibitors on fatty liver in ty..:

Scheen, A.J.
Diabetes & Metabolism.  45 (2019)  3 - p. 213-223 , 2019
Link: https://doi.org/10.1016/..
 
?
11

Effects of glucose-lowering agents on surrogate endpoints a..:

Scheen, A.J.
Diabetes & Metabolism.  45 (2019)  2 - p. 110-121 , 2019
Link: https://doi.org/10.1016/..
 
?
12

Effects of SGLT2 inhibitors on systemic and tissue low-grad..:

Bonnet, F. ; Scheen, A.J.
Diabetes & Metabolism.  44 (2018)  6 - p. 457-464 , 2018
Link: https://doi.org/10.1016/..
 
?
13

Renal outcomes with dipeptidyl peptidase-4 inhibitors:

Scheen, A.J. ; Delanaye, P.
Diabetes & Metabolism.  44 (2018)  2 - p. 101-111 , 2018
Link: https://doi.org/10.1016/..
 
?
14

Haemoglobin A1c and 5-year all-cause mortality in French ty..:

Doucet, J. ; Verny, C. ; Balkau, B...
Diabetes & Metabolism.  44 (2018)  6 - p. 465-472 , 2018
Link: https://doi.org/10.1016/..
 
?
15

Cardiovascular safety of DPP-4 inhibitors compared with sul..:

Scheen, A.J.
Diabetes & Metabolism.  44 (2018)  5 - p. 386-392 , 2018
Link: https://doi.org/10.1016/..
 
1-15